» Articles » PMID: 21549178

A MiR-centric View of Head and Neck Cancers

Overview
Specialties Biochemistry
Biophysics
Date 2011 May 10
PMID 21549178
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Head and Neck Squamous Cell Carcinomas (HNSCCs) constitute the sixth most common cancer worldwide with an average 5-year survival rate of around 50%. Several microRNAs, small non-coding RNAs involved in post-transcriptional gene regulation, have been linked to HNSCC based on their differential expression in tumors. Here, we present a compilation of multiple types of information on each HNSCC linked miRNA including their expression status in tumors, their molecular targets relevant to cancer, results of gene manipulation studies and association with clinical outcome. Further, we use this information to devise a new scheme for classifying them into causal and non-causal miRNAs in HNSCC. We also discuss the possibility of using miRNAs as prognostic and diagnostic biomarkers for HNSCC, based on existing literature. Finally, we present available evidence that shows how altered expression of specific miRNAs can contribute to various "hallmarks of cancer" phenotypes such as limitless replicative potential owing to abnormal cell cycle regulation, evasion of apoptosis, reduced response to anti-growth signals, and Epithelial-Mesechymal transition (EMT).

Citing Articles

MicroRNAs in head and neck squamous cell carcinoma: a possible challenge as biomarkers, determinants for the choice of therapy and targets for personalized molecular therapies.

Vahabi M, Blandino G, Di Agostino S Transl Cancer Res. 2022; 10(6):3090-3110.

PMID: 35116619 PMC: 8797920. DOI: 10.21037/tcr-20-2530.


The Prognostic Role of Micro-RNAs in Head and Neck Cancers: An Umbrella Review.

Mariani M, Castagna C, Boccia S, Pastorino R J Pers Med. 2021; 11(8).

PMID: 34442465 PMC: 8400907. DOI: 10.3390/jpm11080821.


miR-9 modulates and predicts the response to radiotherapy and EGFR inhibition in HNSCC.

Citron F, Segatto I, Musco L, Pellarin I, Rampioni Vinciguerra G, Franchin G EMBO Mol Med. 2021; 13(7):e12872.

PMID: 34062049 PMC: 8261495. DOI: 10.15252/emmm.202012872.


Insight toward the MicroRNA Profiling of Laryngeal Cancers: Biological Role and Clinical Impact.

Takeuchi T, Kawasaki H, Luce A, Cossu A, Misso G, Scrima M Int J Mol Sci. 2020; 21(10).

PMID: 32456271 PMC: 7279294. DOI: 10.3390/ijms21103693.


Circulating MicroRNAs as Prognostic Molecular Biomarkers in Human Head and Neck Cancer: A Systematic Review and Meta-Analysis.

Lamichhane S, Thachil T, Gee H, Milic N Dis Markers. 2019; 2019:8632018.

PMID: 31827646 PMC: 6885815. DOI: 10.1155/2019/8632018.